Richard H.Deane Jr. (Rick)

Of Counsel

Atlanta + 1.404.581.8502

Connect:

Share

Rick Deane represents clients who are facing all types of criminal or civil investigations by the Department of Justice and other investigative agencies. He has extensive experience in federal grand jury investigations, trying cases in state and federal courts, and appearing before the Fifth and Eleventh Circuit Courts of Appeal. Rick served as lead counsel in defending criminal charges against a major design-build company. All charges against the company were dismissed, and the company paid a civil assessment. He also served as lead counsel in a month-long personal injury case tried in state court to a complete defense verdict and handles general litigation matters. Rick is the former Partner-in-Charge of the Atlanta Office and former co-chair of the Investigations & White Collar Defense Practice.

Rick's representative clients include the Atlanta School Board, The Facilities Group, Fulton County District Attorney's Office, The Public Warehousing Company K.S.C., and The Sherwin-Williams Company.

Rick is a member of the American College of Trial Lawyers, serves on the Executive Committee for the College, and is its first African American president-elect (2024). He was chosen by the State Bar of Georgia's bench and bar committee as the attorney recipient of the 12th Annual Chief Justice Thomas O. Marshall Professionalism Award. The award honors "one lawyer and one judge who have demonstrated the highest professional conduct and paramount reputation for professionals." He also received the Atlanta Bar Association's Leadership Award in 2016 and the "Thomas J. Waldrop Truth & Justice Award" in recognition of his representation of Atlanta School Superintendent, Dr. Beverly Hall, during the Atlanta cheating scandal. Rick is a past president of the National Association of Former United States Attorneys (NAFUSA).

Experience

  • Wells Fargo achieves full dismissal with prejudice of systemic fair-lending litigationLocal governments asserting class-action style fair-lending claims concerning alleged residential mortgage practices voluntarily dismissed their claims with prejudice, noting that this dismissal is not the result of any settlement, against Jones Day client, Wells Fargo Bank, National Association affiliates.
  • Minneapolis transforms city policingOn March 31, 2023, the city of Minneapolis and the Minnesota Department of Human Rights (MDHR) filed a 144 page settlement agreement in state court that will fundamentally change the way Minneapolis police engage with its citizens.
  • Sherwin-Williams obtains favorable decision from Seventh Circuit in personal injury casesA Jones Day cross-office, cross-practice team obtained a precedential decision from the Seventh Circuit that directed judgment as a matter of law for The Sherwin-Williams Company following a consolidated trial of three personal injury plaintiffs claiming injury from their exposure to white lead carbonate pigments (WLC).
  • Major university conducts sensitive internal investigationJones Day conducted a sensitive, high-profile investigation for a major national university involving alleged misconduct by senior administrative officials.
  • Former CEO defends federal criminal investigation involving allegations of potential violations of Anti-Kickback statuteJones Day is representing a former CEO in a federal criminal investigation involving allegations of potential violations of the Anti-Kickback statute.
  • Physician-owned Ambulatory Surgery Center issued favorable reconsideration decision in Medicare overpayment appealJones Day represented a physician-owned Ambulatory Surgery Center ("ASC") in a recent appeal on claims wherein C2C Innovative Solutions Medical Center, a Medicare contractor, returned a favorable reconsideration decision for the ASC.
  • Multinational corporation conducts internal investigation of Asia operationsOn behalf of a publicly traded multinational corporation, Jones Day conducted a targeted investigation of alleged misconduct and potential violations of the Foreign Corrupt Practices Act (“FCPA”) in China, Vietnam, and Singapore.
  • Global retailer seeks advice on anti-corruption and anti-bribery compliance policies and proceduresOn behalf of a global, publicly-traded retailer, Jones Day conducted a review of the company’s anti-corruption and anti-bribery policies and procedures, to include the Foreign Corrupt Practices Act ("FCPA") and the U.K. Bribery Act.
  • CEO of industrial services company defends federal criminal public corruption investigationJones Day is representing the chief executive officer of an industrial services company in a federal criminal public corruption investigation involving state public works contracts.
  • Former CFO of multinational corporation defends DOJ and SEC investigation involving allegations of potential FCPA violationsJones Day represents the former chief financial officer of a multinational corporation in a Department of Justice and Securities and Exchange Commission investigation involving allegations of potential violations of the Foreign Corrupt Practices Act.
  • Cardinal Health obtains dismissal of suit alleging pharmaceutical companies contributed to "epidemic of prescription drug abuse"Jones Day client Cardinal Health, Inc. obtained dismissal of a lawsuit filed by Fulton County, Georgia that alleged Cardinal Health and other pharmaceutical distribution companies were to blame for a growing prescription-drug epidemic.
  • Former Atlanta School Superintendent Beverly Hall defends allegations of cheating on standardized testsJones Day represented former Atlanta School Superintendent Beverly Hall in connection with allegations of cheating on standardized tests by school system personnel.
  • Multinational corporation conducts pre-acquisition due diligence of target company subject to federal grand jury investigationOn behalf of a publicly traded multinational corporation, Jones Day conducted pre-acquisition due diligence of a target company subject to a federal grand jury investigation related to potential violations of the Controlled Substances Act.
  • Multinational industrial services corporation involved in state public corruption investigation related to government services contractsJones Day represented a publicly traded multinational industrial services corporation in a state public corruption investigation related to government services contracts.
  • Multinational corporation conducts internal investigation of Brazil operationJones Day conducted a targeted investigation of alleged misconduct and potential violations of the Foreign Corrupt Practices Act in a multinational corporation’s Brazilian operation.
  • Multinational corporation conducts internal investigation related to fatal worksite employee accidentOn behalf of a publicly traded global corporation, Jones Day conducted an internal investigation into a fatal worksite employee accident, specifically focused on employee statements and company reports that had been provided to investigating government agencies.
  • Multinational equipment manufacturer conducts internal investigation of possible FCPA violations in Mexico operationsOn behalf of a publicly traded multinational equipment manufacturer, Jones Day conducted a targeted investigation of alleged misconduct and potential violations of the Foreign Corrupt Practices Act in Mexico.
  • Multinational corporation conducts global FCPA compliance reviewOn behalf of a publicly traded, multinational corporation, Jones Day conducted a targeted global Foreign Corrupt Practices Act compliance review of the corporation's operations in Brazil, China, India, South Korea, and Uzbekistan.
  • Health care services company wins partial summary judgment in commercial disputeJones Day represented a health care services company in a commercial dispute over invoices with a former freight, pay, and audit service provider.
  • Major university undergoes internal investigation involving graduate business school student selectivity dataAs publicly reported, Jones Day conducted an independent investigation into the external misreporting of certain graduate business school student selectivity data by a major University.
    • View All

    October 2023 White Paper

    Considerations for Addressing DOJ's Corporate Compliance Guidance on Mobile Devices and Messaging Platforms

    March 2023 White Paper

    DOJ Announces New Voluntary Self-Disclosure Policy for All U.S. Attorneys' Offices

    January 2023 Commentary

    DOJ Criminal Division Announces Revisions to its Corporate Enforcement Policy

    November 2022 White Paper

    Conducting an Effective Internal Investigation: An Overview

    July 2022 Firm Hosted

    Jones Day's Atlanta Office welcomes GAPABA and SABA-GA

    November 2021 Commentary

    DOJ Announces Policy Changes and Additional Resources Focused on White-Collar Enforcement

    September 2021 White Paper

    Diversity in Monitorship Selection

    December 2020 White Paper

    Criminal Jury Trials in a Global Pandemic: Safeguarding the Constitutional Rights of the Accused

    July 2020 Commentary

    DOJ and SEC Publish Second Edition of the FCPA Resource Guide

    May 2020 White Paper

    A Guide to Navigating the COVID-19 Crisis for Institutions of Higher Education

    View All

    Speaking Engagements

    • February 13, 2017
      Advanced Issues in Internal Investigations, Jones Day CLE Academy
    • February 24, 2016
      Rick Deane Speaks at University of Georgia Law School
    • July 28, 2014
      Atlanta Office sponsors rededication of the newly restored WWI memorial in Pershing Point Park
    • December 12, 2013
      Health Care Fraud, Don't Spiral Out of Control: How to Effectively Address Problems Through Internal Investigations
    • October 8, 2013
      Current Issues in FCPA Compliance – Meet Our Professionals From Around the World
    • June 6, 2013
      International Business and Crimes FCPA
    • June 4, 2013
      Society of Corporate Compliance and Ethics's 11th Annual Higher Education Compliance Conference
    • March 20, 2013
      Georgia's New 2012 False Claims Act and Update on Qui Tam, SEC, and IRS Whistleblower Claims
    • December 13, 2012
      Health Care Fraud Institute, State Bar of Georgia Conference
    • April 25, 2012
      International Business and Crime, FCPA, Criminal Antitrust
    • February 3, 2012
      Discussion on Government Investigations, Atlanta Chapter of the Federal Bar Association
    • March 2, 2011
      Corporate Compliance: Recent Developments and Trends
    • January 28, 2011
      White Collar Crime, Grand Jury Practice: Avoiding Missteps That Could Endanger The Client
    • December 16, 2010
      Southeastern Health Care Fraud Institute: Affirmative Responses to Government Action
    • October 15, 2010
      Sentencing in the Eleventh Circuit-In Search of a Reasonable Sentence
    • October 6, 2010
      Corporate Internal Investigations: Delivering the News
    • September 29, 2010
      18th Annual Diversity CLE and Luncheon
    • September 2, 2010
      Foreign Corrupt Practices Act (FCPA): International Business and Crime - An Overview, Institute of Continuing Legal Education of Georgia
    • March 26-27, 2009
      Corporate Compliance and Ethics Institute 2009
    • March 19, 2008
      Designing The Investigation: Personnel, Scope and Audiences
    • March 30, 2007
      The Role of the Board, panelist, Corporate Compliance and Ethics Institute, Practicing Law Institute
    • March 29-30, 2007
      Director Liability/Responsibility
    • April 2006
      Corporate Compliance Institute 2006
    • September 22, 2005
      Challenges to Ethics and Professionalism in White Collar Criminal Cases, White Collar Crime Seminar
    • February 25, 2005
      Prosecutional Ethics, State-wide U.S. Attorney's Conference, meeting of all districts in the state

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.